Giudici Michael C, Ahmad Ferhaan, Holanda Danniele G
Department of Medicine, University of Iowa Hospitals, 200 Hawkins Drive, 4426JCP, Iowa City, IA, USA.
Department of Pathology, University of Iowa Hospitals, 200 Hawkins Drive, 4426JCP, Iowa City, IA, USA.
Eur Heart J Case Rep. 2019 Jun 1;3(2). doi: 10.1093/ehjcr/ytz038.
PRKAG2 syndrome (PS) is a rare, early-onset autosomal dominant inherited disease caused by mutations in PRKAG2, the gene encoding the regulatory γ2 subunit of adenosine monophosphate-activated protein kinase. PRKAG2 syndrome is associated with many cardiac manifestations, including pre-excitation, arrhythmias, left ventricular hypertrophy, and chronotropic incompetence frequently leading to early pacemaker placement. A meta-analysis of genome-wide association data in subjects with chronic kidney disease (CKD) identified a susceptibility locus in an intron of PRKAG2, which has been replicated in other studies. However, CKD has not been reported in patients with PS or mutations in PRKAG2.
We report a case of a woman diagnosed at age 27 with PS when she presented with atrial fibrillation and pre-excitation on electrocardiogram. By age 35, she had developed mild renal insufficiency and a biopsy demonstrated IgA nephropathy (IGAN).
This is the first reported case of IGAN in a patient with PS. We discuss both PS and IGAN and the potential mechanisms by which they could be related.
PRKAG2综合征(PS)是一种罕见的早发性常染色体显性遗传病,由PRKAG2基因突变引起,该基因编码单磷酸腺苷激活蛋白激酶的调节性γ2亚基。PRKAG2综合征与许多心脏表现相关,包括预激、心律失常、左心室肥厚和变时性功能不全,常导致早期起搏器植入。一项对慢性肾脏病(CKD)患者全基因组关联数据的荟萃分析在PRKAG2基因的一个内含子中确定了一个易感位点,该位点已在其他研究中得到重复验证。然而,尚未有PS患者或PRKAG2基因突变患者出现CKD的报道。
我们报告一例27岁女性患者,因心电图显示房颤和预激而被诊断为PS。到35岁时,她出现了轻度肾功能不全,活检显示为IgA肾病(IGAN)。
这是首例报道的PS患者合并IGAN的病例。我们讨论了PS和IGAN以及它们可能相关的潜在机制。